Novartis Market Sentiment

Novartis AG

NVSNYSE

$159.99

-3.10-1.9%

al cierre: Sep 4, 5:00 PM EST

$152.50

-7.49-4.68%

After hour: Sep 4, 7:52 PM EST

Market sentiment signals for Novartis (NVS): analyst consensus, short interest, options flow and insider activity.

Analyst Consensus— Overweight

Short Interest▲ 0.3% short float

Options Flow▲ 0.61 P/C ratio

Insider Activity— N/A

Analyst Consensus

Overweight

11 analysts

Options Flow (P/C)

0.61

More calls — Bullish

2,483 calls · 1,523 puts

Avg Consensus PT

$135

-11.8%

Highest Price Target

$170

+11.5%

Morgan Stanley

Lowest Price Target

$118

-22.6%

Goldman Sachs

Short Interest

0.3%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Mar 26, 2026	Morgan Stanley	Mark Purcell—	+11.5%	$143 → $170	Maintained	Overweight
Jan 6, 2026	Barclays	Emmanuel Papada—	—	—	Upgrade	Underweight→Equal-Weight
Dec 8, 2025	JP Morgan	Richard Vosser—	—	—	Upgrade	Neutral→Overweight
Oct 27, 2025	Jefferies	Michael Leuchten—	—	—	Assumes	Hold
Sep 12, 2025	Goldman Sachs	James Quigley—	-22.6%	$119 → $118	Downgrade	Neutral→Sell
Feb 13, 2025	UBS	Matthew Weston—	—	—	Downgrade	Buy→Neutral
Nov 19, 2024	Erste Group	Hans Engel—	—	—	Downgrade	Buy→Hold
Oct 30, 2024	BMO Capital	Etzer Darout—	-21.3%	$118 → $120	Maintained	Market Perform
Sep 11, 2024	B of A Securities	Graham Perry—	-14.8%	$135 → $130	Downgrade	Buy→Neutral
Sep 5, 2024	Goldman Sachs	James Quigley—	-20.7%	$119 → $121	Downgrade	Buy→Neutral
Sep 3, 2024	Jefferies	Peter Welford—	—	—	Downgrade	Buy→Hold
Jul 2, 2024	Jefferies	Peter Welford—	-19.7%	$121 → $123	Maintained	Buy
Apr 24, 2024	BMO Capital	Etzer Darout—	-23.9%	$114 → $116	Maintained	Market Perform
Feb 23, 2024	BMO Capital	Etzer Darout—	-25.2%	$114	Initiate	Market Perform
Jan 23, 2024	Morgan Stanley	Mark Purcell—	-25.2%	$114	Initiate	Equal-Weight
Sep 25, 2023	Morgan Stanley	Vincent Meunier—	—	—	Upgrade	Underweight→Equal-Weight